Artículos discutidos

| ensayo | revisión | diagnóstico | pronóstico | económica | series de casos | otros |

Artículos de tipo 'ensayo' discutidos:

  • 53.- Zuckerman J.D., Skovron M.L., Koval K.J., Aharanoff G., Frankel V.H. Postoperative Complications and Mortality Associated with Operative Delay in Older Patients Who Have a Fracture of the Hip. J of Bone and Joint Surgery 1995; 77: 1551-1556
  • 54.- Bonet S, Agustí A, Arnau J.M, Vidal X, Diogène E, Galve E, Laporte J.R. ß - Adrenergic Blocking Agents in Heart Failure. Arch Intern Med 2000; 160:621-627
  • 56.- Silverstein F.E., Faich G., Goldstein J.L., et al.Gastrointestinal Toxicity UIT Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis.The CLASS Study: A Randomized Controlled Trial JAMA 2000; 284: 1247-1255.
  • 57.- Yusuf S., Zhao F., Mehta SR., Chrolavicius S., Tognoni G., Fox KK. Effects of Clopidogrel in addition to aspirin in patientes with acute coronary syndromes without ST-segment elvation. N Engl J Med 2001;345:494-502.
  • 64.- Chiba N, Veldhuyzen SJO, Sinclair P et al. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp)) randomised controlled trial. BMJ 2002;324:1012-1018
  • 66.- Hurlen M, Abdelnoor M, Smith P, et al. WARFARIN, ASPIRIN, OR BOTH AFTER MYOCARDIAL INFARCTION. N Engl J Med, 2002;347:969-974
  • 68.- Blue L, Lang E, Mc Murray JJ, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001;323: 715-718
  • 71.- Chan FKL, Hung LCT, Suen BY et al. Celecoxib versus Diclofenac and Omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Eng J Med 2002;347:2104-2110
  • 72.- Jorenby D.E., Leischow S.J., Nides M.A. et al. A Controlled trial of sustained-release Bupropion, a Nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340 (9): 685-691
  • 73.- Dahlof B, Devereux RB, Kjeldsen SE y cols.:Morbilidad y mortalidad cardiovasculares en el estudio Losartan Intervention For Endpoint reduction in hipertensión (LIFE): ensayo aleatorizado de comparación con atenolol. THE LANCET 2002; 359: 995-1003.
← 1 2 3 4 5 6 7 8 9 10 →